[
  {
    "text": "<p>New funding applications are referred to one of Pharmac's Funding Application Advisors (FAAs), who'll review the application to ensure they have the relevant information to undertake a preliminary analysis.&nbsp; They may seek more information if required.</p>\r\n<p><a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/</a></p>",
    "position": 0,
    "name": "Application Received",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2012",
          "fs": "Aug 2012",
          "change": null
        },
        "Event_Description": {
          "s": "Application received",
          "fs": "Application received",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rsv2AF"
          },
          "Id": "a0POZ00000R5Rsv2AF",
          "Event_Date__c": "2012-08-01",
          "Event_Description__c": "Application received",
          "Stage__c": "Application Received",
          "Formatted_Date__c": "Aug 2012",
          "Status_History__c": "a132P000000Aq4KQAS"
        },
        "change": null
      }
    ],
    "dateString": "Aug 2012",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac is identifying and gathering information required to get clinical advice.  The <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/\" rel=\"nofollow\">Pharmacology and Therapeutics Advisory Committee (PTAC)</a>  meets quarterly. There are also around 20 expert <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/\" rel=\"nofollow\">Specialist Advisory Committees (SACs)</a>, previously expert Subcommittees, which provide clinical evaluations in specialist areas. Specialist Advisory Committees meet as required to discuss issues referred to them by PTAC or Pharmac.</p>\n<p style=\"height: 20px\">&nbsp;</p>\n<p>In November 2021, we introduced separate terms of reference for the SACs to make clear that these committees have different, but complementary, roles, expertise and perspectives to PTAC.</p>\n<p style=\"height: 15px\">&nbsp;</p>\n<p>PTAC and SACs may make recommendations to Pharmac that differ from each other when looking at the same evidence. Pharmac considers the recommendations provided by all our clinical advisory committees when assessing applications.</p>\n<p style=\"height: 20px\">&nbsp;</p>\n<p><a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/ptac-terms-of-reference-july-2021/\" rel=\"nofollow\">PTAC</a>  and <a class=\"external-link\" href=\"https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/specialist-advisory-committee-terms-of-reference//\" rel=\"nofollow\">Specialist Advisory Committees</a> records of the meeting will be published on this website in accordance with the Terms of Reference.</p>",
    "position": 1,
    "name": "Seeking Clinical Advice",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Mar 2013",
          "fs": "Mar 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice required",
          "fs": "Clinical advice required",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rsw2AF"
          },
          "Id": "a0POZ00000R5Rsw2AF",
          "Event_Date__c": "2013-03-01",
          "Event_Description__c": "Clinical advice required",
          "Stage__c": "Seeking Clinical Advice",
          "Formatted_Date__c": "Mar 2013",
          "Status_History__c": "a132P000000AqLLQA0"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "The Subcommittee considered the overall level of the evidence for calcium  phosphate mouthwash to be poor for use in chemoradiotherapy., With limited  patient numbers in the single RCT for its use in HSCT, and the other evidence  from studies with poor design that were inadequately powered, its use could not  be recommended currently.    The Subcommittee recommended that funding of calcium phosphate mouthwash  be declined.",
          "fs": "The Subcommittee considered the overall level of the evidence for calcium  phosphate mouthwash to be poor for use in chemoradiotherapy., With limited  patient numbers in the single RCT for its use in HSCT, and the other evidence  from studies with poor design that were inadequately powered, its use could not  be recommended currently.    The Subcommittee recommended that funding of calcium phosphate mouthwash  be declined.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "fs": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-catsop-subcommittee-minutes-2013-03-22.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-catsop-subcommittee-minutes-2013-03-22.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Mar 2013",
          "fs": "Mar 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 22 March 2013.",
          "fs": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 22 March 2013.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rsx2AF"
          },
          "Id": "a0POZ00000R5Rsx2AF",
          "Event_Date__c": "2013-03-22",
          "Event_Description__c": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 22 March 2013.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-catsop-subcommittee-minutes-2013-03-22.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "Outcome__c": "Decline",
          "Summary__c": "The Subcommittee considered the overall level of the evidence for calcium  phosphate mouthwash to be poor for use in chemoradiotherapy., With limited  patient numbers in the single RCT for its use in HSCT, and the other evidence  from studies with poor design that were inadequately powered, its use could not  be recommended currently.    The Subcommittee recommended that funding of calcium phosphate mouthwash  be declined.",
          "Formatted_Date__c": "Mar 2013",
          "PTAC_Comments__c": "These minutes have been ratified by the Pharmacology and Therapeutic Advisory Committee.",
          "Status_History__c": "a132P000000AqLtQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2013",
          "fs": "Aug 2013",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Friday 30 August 2013.",
          "fs": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Friday 30 August 2013.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rsy2AF"
          },
          "Id": "a0POZ00000R5Rsy2AF",
          "Event_Date__c": "2013-08-30",
          "Event_Description__c": "Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Friday 30 August 2013.",
          "Stage__c": "Seeking Clinical Advice",
          "Outcome__c": "Decline",
          "Formatted_Date__c": "Aug 2013",
          "Status_History__c": "a132P000000AqSEQA0"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Apr 2018",
          "fs": "Apr 2018",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice required",
          "fs": "Clinical advice required",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rt12AF"
          },
          "Id": "a0POZ00000R5Rt12AF",
          "Event_Date__c": "2018-04-13",
          "Event_Description__c": "Clinical advice required",
          "Stage__c": "Seeking Clinical Advice",
          "Formatted_Date__c": "Apr 2018",
          "Status_History__c": "a132P000000ArReQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "Decline",
          "fs": "Decline",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-cancer-treatment-subcommittee-minutes-2018-04.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-cancer-treatment-subcommittee-minutes-2018-04.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Apr 2018",
          "fs": "Apr 2018",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 13 April 2018.",
          "fs": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 13 April 2018.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rt22AF"
          },
          "Id": "a0POZ00000R5Rt22AF",
          "Event_Date__c": "2018-04-13",
          "Event_Description__c": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 13 April 2018.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-cancer-treatment-subcommittee-minutes-2018-04.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "Outcome__c": "Decline",
          "Formatted_Date__c": "Apr 2018",
          "Status_History__c": "a132P000000ArRfQAK"
        },
        "change": null
      },
      {
        "Summary": {
          "s": "The Subcommittee noted correspondence from the supplier of Caphasol in response to the April 2018 CaTSoP minute regarding consideration of its funding application for calcium phosphate mouthwash (Caphasol Dispersible) for oral mucositis; which it had recommended be declined primarily based on poor quality evidence.   The Subcommittee noted that the supplier had referenced supplementary studies to support its application but considered that these were also of poor quality and did not add significantly to the overall poor evidence base for use of calcium phosphate mouthwash for oral mucositis.",
          "fs": "The Subcommittee noted correspondence from the supplier of Caphasol in response to the April 2018 CaTSoP minute regarding consideration of its funding application for calcium phosphate mouthwash (Caphasol Dispersible) for oral mucositis; which it had recommended be declined primarily based on poor quality evidence.   The Subcommittee noted that the supplier had referenced supplementary studies to support its application but considered that these were also of poor quality and did not add significantly to the overall poor evidence base for use of calcium phosphate mouthwash for oral mucositis.",
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": "No Formal Recommendation",
          "fs": "No Formal Recommendation",
          "change": null
        },
        "Links": {
          "s": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-cancer-treatment-subcommittee-minutes-2018-09.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "fs": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-cancer-treatment-subcommittee-minutes-2018-09.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Sep 2018",
          "fs": "Sep 2018",
          "change": null
        },
        "Event_Description": {
          "s": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 21 September 2018.",
          "fs": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 21 September 2018.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rt32AF"
          },
          "Id": "a0POZ00000R5Rt32AF",
          "Event_Date__c": "2018-09-21",
          "Event_Description__c": "Clinical advice received from Cancer Treatments Subcommittee (CaTSoP) at meeting Friday 21 September 2018.",
          "Stage__c": "Seeking Clinical Advice",
          "Links__c": "<a href=\"https://www.pharmac.govt.nz/assets/ptac-cancer-treatment-subcommittee-minutes-2018-09.pdf\" target=\"_blank\">CaTSoP Subcommittee minutes</a>",
          "Outcome__c": "No Formal Recommendation",
          "Summary__c": "The Subcommittee noted correspondence from the supplier of Caphasol in response to the April 2018 CaTSoP minute regarding consideration of its funding application for calcium phosphate mouthwash (Caphasol Dispersible) for oral mucositis; which it had recommended be declined primarily based on poor quality evidence.   The Subcommittee noted that the supplier had referenced supplementary studies to support its application but considered that these were also of poor quality and did not add significantly to the overall poor evidence base for use of calcium phosphate mouthwash for oral mucositis.",
          "Formatted_Date__c": "Sep 2018",
          "Status_History__c": "a132P000000ArXmQAK"
        },
        "change": null
      }
    ],
    "dateString": "Mar 2013",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Following Clinical Advice, Pharmac staff considers the advice and the funding application under goes an assessment using our&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/factors-for-consideration/\" rel=\"nofollow\">Factors for Consideration</a>&nbsp;framework and seeks additional information as required.</p>\r\n<p>&nbsp;</p>\r\n<p>Research and Economic analysis are undertaken.&nbsp; This focuses on the costs and benefits of a proposed course of action. Economics is based on three fundamental concepts that summarise the issues Pharmac faces daily:&nbsp;</p>\r\n<ul>\r\n<li>Scarcity &ndash; resources will always be insufficient to support all possible activities.</li>\r\n<li>Choices &ndash; due to scarce resources, decisions must be made about how best to use them.</li>\r\n<li>Opportunity cost &ndash; by choosing to use resources one way, we forgo other opportunities to use the same resources.</li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p>For further information on the purpose of, and techniques for, undertaking economic analysis in health care, please refer&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/</a></p>",
    "position": 2,
    "name": "Under Assessment",
    "last": false,
    "events": null,
    "dateString": null,
    "collapsed": false,
    "checked": false
  },
  {
    "text": "<p>Pharmac staff uses a prioritisation process to compare and rank funding options. Possible opportunities for new investment will always exceed the budget Pharmac has available; therefore, prioritisation is an intrinsic part of Pharmac\u2019s decision-making process.</p>\r\n<p>The relative ranking of options aims to support Pharmac&rsquo;s statutory objective &ldquo;to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided&rdquo;.</p>\r\n<p>A funding application or proposal is considered ready for prioritisation when sufficient information is available to permit it to be reviewed against Pharmac's Factors for Consideration and to inform a comparison with other possible investment decisions.</p>\r\n<p>There is no guarantee when or if a ranked medicine will be funded.&nbsp;&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/</a></p>",
    "position": 3,
    "name": "Options Compared",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Nov 2013",
          "fs": "Nov 2013",
          "change": null
        },
        "Event_Description": {
          "s": "The relative ranking of the pharmaceutical application has been completed.",
          "fs": "The relative ranking of the pharmaceutical application has been completed.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rsz2AF"
          },
          "Id": "a0POZ00000R5Rsz2AF",
          "Event_Date__c": "2013-11-05",
          "Event_Description__c": "The relative ranking of the pharmaceutical application has been completed.",
          "Stage__c": "Options Compared",
          "Formatted_Date__c": "Nov 2013",
          "Status_History__c": "a132P000000AqVSQA0"
        },
        "change": null
      },
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Oct 2017",
          "fs": "Oct 2017",
          "change": null
        },
        "Event_Description": {
          "s": "Received Additional Information",
          "fs": "Received Additional Information",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rt02AF"
          },
          "Id": "a0POZ00000R5Rt02AF",
          "Event_Date__c": "2017-10-24",
          "Event_Description__c": "Received Additional Information",
          "Stage__c": "Options Compared",
          "Formatted_Date__c": "Oct 2017",
          "Status_History__c": "a132P000000ArM1QAK"
        },
        "change": null
      }
    ],
    "dateString": "Nov 2013",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Pharmac is consulting on a proposal to either approve or decline the application.&nbsp;We seek the views of all people who have an interest in our proposals, or who may be affected by them, to obtain feedback on our proposed approaches.</p>\r\n<p><a class=\"external-link\" href=\"https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/\" rel=\"nofollow\">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/</a></p>",
    "position": 4,
    "name": "Under Consultation",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications\" target=\"_blank\">https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications</a></p>",
          "fs": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications\" target=\"_blank\">https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications</a></p>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Jun 2021",
          "fs": "Jun 2021",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is active.",
          "fs": "Public consultation for this application is active.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rt42AF"
          },
          "Id": "a0POZ00000R5Rt42AF",
          "Event_Date__c": "2021-06-28",
          "Event_Description__c": "Public consultation for this application is active.",
          "Stage__c": "Under Consultation",
          "Links__c": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications\" target=\"_blank\">https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/2021-06-29-proposal-to-decline-inactive-funding-applications</a></p>",
          "Formatted_Date__c": "Jun 2021",
          "Status_History__c": "a132P000000CxdmQAC"
        },
        "change": null
      }
    ],
    "dateString": "Jun 2021",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>Following the consultation process, Pharmac staff considers the feedback and identifies any additional information required as part of a gap analysis.&nbsp; The proposal may require further clinical advice, research, and assessment.</p>",
    "position": 5,
    "name": "Reviewing Consultation Feedback",
    "last": false,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Formatted_Date": {
          "s": "Aug 2021",
          "fs": "Aug 2021",
          "change": null
        },
        "Event_Description": {
          "s": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "fs": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rt52AF"
          },
          "Id": "a0POZ00000R5Rt52AF",
          "Event_Date__c": "2021-08-02",
          "Event_Description__c": "Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.",
          "Stage__c": "Reviewing Consultation Feedback",
          "Formatted_Date__c": "Aug 2021",
          "Status_History__c": "a132P000000D3rjQAC"
        },
        "change": null
      }
    ],
    "dateString": "Aug 2021",
    "collapsed": false,
    "checked": true
  },
  {
    "text": "<p>We refer to our decisions about whether and how particular pharmaceuticals are publicly-funded, as &ldquo;funding decisions&rdquo;.</p>\r\n<p>We consider and assess all funding decisions using the&nbsp;<a class=\"external-link\" href=\"https://www.pharmac.govt.nz/about/operating-policies-and-procedures/#factorsfc\" rel=\"nofollow\">Factors for Consideration</a>. When we do so, we carefully evaluate clinical and other evidence for the benefits and suitability of a proposal, and to identify and understand the people who will be affected by it.</p>\r\n<p>While our main task is to allocate pharmaceutical funding, we consider the benefits and costs across the whole health system now and with a long-term focus, including the effects for hospitals and primary care, and consider direct costs to patients as well as to all health sector budgets.</p>\r\n<p>Final funding decisions are made by the Pharmac Board or delegated to senior Pharmac staff as required by the Board.</p>\r\n<p>&nbsp;</p>",
    "position": 6,
    "name": "Decision",
    "last": true,
    "events": [
      {
        "Summary": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Recommendation": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Discussion": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Published_Application": {
          "s": null,
          "fs": null,
          "change": null
        },
        "PTAC_Comments": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Outcome": {
          "s": null,
          "fs": null,
          "change": null
        },
        "Links": {
          "s": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2022-03-08-inactive-declines/\" target=\"_blank\">Notification letter</a></p>",
          "fs": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2022-03-08-inactive-declines/\" target=\"_blank\">Notification letter</a></p>",
          "change": null
        },
        "Formatted_Date": {
          "s": "Feb 2022",
          "fs": "Feb 2022",
          "change": null
        },
        "Event_Description": {
          "s": "The funding application has been declined.",
          "fs": "The funding application has been declined.",
          "change": null
        },
        "e": {
          "attributes": {
            "type": "Application_Event__c",
            "url": "/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000R5Rt62AF"
          },
          "Id": "a0POZ00000R5Rt62AF",
          "Event_Date__c": "2022-02-04",
          "Event_Description__c": "The funding application has been declined.",
          "Stage__c": "Decision",
          "Links__c": "<p><a href=\"https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-2022-03-08-inactive-declines/\" target=\"_blank\">Notification letter</a></p>",
          "Formatted_Date__c": "Feb 2022",
          "Status_History__c": "a132P000000Dao8QAC"
        },
        "change": null
      }
    ],
    "dateString": "Feb 2022",
    "collapsed": false,
    "checked": true
  }
]